Amneal Pharmaceuticals, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP AMRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,090,424

Value ($000)

13,739

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	13,739	0.0%	1,090,424	12/31/2025
2025 Q3	11/13/2025	12,991	0.0%	1,297,762	9/30/2025
2025 Q2	8/13/2025	13,731	0.0%	1,697,225	6/30/2025
2025 Q1	5/14/2025	15,029	0.0%	1,793,453	3/31/2025
2024 Q4	2/12/2025	12,205	0.0%	1,541,058	12/31/2024
2024 Q3	11/14/2024	17,214	0.0%	2,068,979	9/30/2024
2024 Q2	8/14/2024	5,076	0.0%	799,338	6/30/2024
2024 Q1	5/15/2024	3,829	0.0%	631,908	3/31/2024
2023 Q4	2/14/2024	1,285	0.0%	211,674	12/31/2023
2023 Q3	11/14/2023	3,387	0.0%	802,588	9/30/2023
2023 Q2	8/14/2023	2,830	0.0%	912,974	6/30/2023
2023 Q1	5/15/2023	947	0.0%	681,017	3/31/2023
2022 Q4	2/14/2023	990	0.0%	497,474	12/31/2022
2022 Q1	5/13/2022	1,457	0.0%	349,320	3/31/2022
2021 Q4	2/14/2022	970	0.0%	202,566	12/31/2021
2021 Q3	11/12/2021	487	0.0%	91,290	9/30/2021
2021 Q2	8/13/2021	1,276	0.0%	249,160	6/30/2021
2021 Q1	5/14/2021	3,444	0.0%	511,752	3/31/2021
2020 Q3	11/12/2020	443	0.0%	114,213	9/30/2020
2020 Q2	8/12/2020	6,136	0.0%	1,289,082	6/30/2020
2020 Q1	5/15/2020	693	0.0%	199,263	3/31/2020
2019 Q4	2/13/2020	934	0.0%	193,736	12/31/2019